Neurizon Therapeutics Health Care
Biotech Healthcare

$TBC

High $0.06	Low $0.06	Trades -	Turnover $0	Volume 416,264
24 July 2026 at 8:06pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NUZ	Name Neurizon Therapeutics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 775,099,508	Shares Floated 406,101,348	Held by Insiders 24.405%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Mr. Sergio Duchini	Interim Executive Chairman
Mr. Dan O'Connell	Chief Financial Officer
Mr. John Clark	Chief Operating Officer
Ms. Lidija Damjanovic	Head of Marketing & Corporate Affairs
Dr. Gary Pitt	Head of Chemistry
Dr. James Rixson	Head of Production
Dr. Herbert Brinkman	Head of Manufacturing
Dr. Chris Freitag M.D.	Chief Medical Advisor
Dr. Martin Engel	Head of Business Development
Mr. Stefan Ross	Company Secretary

NUZ Historic Dividends

Date	Amount
We found no dividends on record for NUZ.

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.06	731,546	0.00 (1.59%)
22-Jul	$0.06	416,264	0.00 (1.56%)
21-Jul	$0.06	803,321	0.00 (1.54%)
20-Jul	$0.07	815,411	+0.00 (3.17%)
17-Jul	$0.06	1,423,900	-0.08 (56.55%)
18-Sep	$0.15	539,828	-0.01 (3.33%)
11-Sep	$0.15	171,367	0.00 (0.00%)
05-Sep	$0.15	119,692	0.00 (0.00%)
04-Sep	$0.15	37,961	0.00 (0.00%)
03-Sep	$0.15	505,002	-0.01 (3.23%)
29-Aug	$0.16	26,990	0.00 (0.00%)
28-Aug	$0.16	80,283	0.00 (0.00%)
22-Aug	$0.16	697,848	-0.01 (3.13%)
21-Aug	$0.16	336,154	+0.01 (6.67%)
15-Aug	$0.15	1,524,780	-0.02 (11.76%)
2 up, 8 down, and 5 flat days

Market Cap (23-Jul) $48,056,168	EBITDA -	PE 5.33	Book Value $0.02
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.03	Profit Margin N/A
Operating Margin -90.98%	ROA 60.21%	ROE 147.09%	Revenue (FY) $5,979,498
Revenue per Share $0.01	Gross Profit (FY) $5,979,498	Q' YOY Revenue Growth 290%	Q' YOY Earnings Growth -

Neurizon Therapeutics Health Care
Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NUZ Historic Dividends

Followers

Prices

Announcements

End of Day Prices

NUZ Neurizon Therapeutics Health Care Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NUZ Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Neurizon Therapeutics Health Care
Biotech Healthcare